lansoprazole
Also known as A-65006, AG-1749, AG 1749
Lansoprazole, sold under the brand name Prevacid among others, is a medication which reduces stomach acid. It is a proton pump inhibitor (PPI), used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. Its effectiveness is similar to that of other PPIs. It is taken by mouth. Onset is over a few hours and effects last up to a couple of days.
Key facts
- Drug.ATC_suffix
- BC03
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458267412
- Drug.image
- Lansoprazole.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 245
- Drug.image2
- Lansoprazole_3D_Xtal_Ball-and-Stick.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250
- Drug.chirality
- Racemic mixture
- Drug.tradename
- Prevacid, others
- Drug.MedlinePlus
- a695020
- Drug.DailyMedID
Article
10 sectionsContents
- Medical uses
- Side effects
- Interactions
- Chemistry
- History
- Society and culture
- Patents
- Availability
- Research
- References
{{Infobox drug | Watchedfields = changed | verifiedrevid = 458267412 | image = Lansoprazole.svg | image_class = skin-invert-image | width = 245 | alt = | image2 = Lansoprazole_3D_Xtal_Ball-and-Stick.png | image_class2 = bg-transparent | width2 = 250 | alt2 = | caption = | chirality = Racemic mixture
| pronounce = | tradename = Prevacid, others | Drugs.com = | MedlinePlus = a695020 | DailyMedID = Lansoprazole | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, intravenous | class = Proton pump inhibitor | ATCvet = | ATC_prefix = A02 | ATC_suffix = BC03 | ATC_supplemental = | legal_AU = S2, S3, & S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = OTC | legal_US_comment = /Rx-only | legal_EU = | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status =
Gallery (3)
Connections
Categories
BenzimidazolesCYP2C19 inhibitorsDrugboxes which contain changes to watched fieldsDrugs developed by AbbVieDrugs developed by GSK plcDrugs developed by NovartisDrugs developed by Takeda Pharmaceutical CompanyDrugs with non-standard legal statusECHA InfoCard ID from WikidataOrganofluoridesOver-the-counter drugs in the United StatesPhenol ethers